Market Closed -
Toronto S.E.
01:29:59 11/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.37
CAD
|
+2.78%
|
|
-7.50%
|
-47.14%
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
38.15
|
55.19
|
326.4
|
234.5
|
243.9
|
112.3
|
-
|
-
|
Enterprise Value (EV)
1 |
38.15
|
55.19
|
326.4
|
234.5
|
235.1
|
88.65
|
94.55
|
112.3
|
P/E ratio
|
-9.75
x
|
-6.63
x
|
-41.7
x
|
-8.89
x
|
-5.85
x
|
-3.29
x
|
-3.15
x
|
-4.63
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
560
x
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
560
x
|
EV / EBITDA
|
-9.67
x
|
-11
x
|
-48.9
x
|
-9.64
x
|
-5.87
x
|
-2.61
x
|
-2.83
x
|
-4.19
x
|
EV / FCF
|
-
|
-
|
-46.2
x
|
-3.86
x
|
-7.72
x
|
23
x
|
-3.07
x
|
-
|
FCF Yield
|
-
|
-
|
-2.17%
|
-25.9%
|
-12.9%
|
4.36%
|
-32.6%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
18.4
x
|
6.17
x
|
9.25
x
|
-
|
Nbr of stocks (in thousands)
|
1,95,660
|
2,08,263
|
2,61,133
|
2,93,125
|
3,20,857
|
3,03,408
|
-
|
-
|
Reference price
2 |
0.1950
|
0.2650
|
1.250
|
0.8000
|
0.7600
|
0.3700
|
0.3700
|
0.3700
|
Announcement Date
|
14/02/20
|
01/02/21
|
14/02/22
|
26/01/23
|
29/01/24
|
-
|
-
|
-
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.2003
|
EBITDA
1 |
-3.947
|
-5.035
|
-6.669
|
-24.31
|
-40.06
|
-33.93
|
-33.36
|
-26.81
|
EBIT
1 |
-
|
-
|
-6.937
|
-24.75
|
-40.5
|
-31.3
|
-35.9
|
-43.4
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-21,664.25%
|
Earnings before Tax (EBT)
1 |
-3.971
|
-5.321
|
-6.966
|
-24.42
|
-39
|
-31.3
|
-35.8
|
-43.1
|
Net income
1 |
-3.971
|
-5.321
|
-6.966
|
-24.42
|
-39
|
-31.3
|
-25.56
|
-27.34
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-13,645.24%
|
EPS
2 |
-0.0200
|
-0.0400
|
-0.0300
|
-0.0900
|
-0.1300
|
-0.1125
|
-0.1175
|
-0.0800
|
Free Cash Flow
1 |
-
|
-
|
-7.073
|
-60.76
|
-30.44
|
3.861
|
-30.84
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/02/20
|
01/02/21
|
14/02/22
|
26/01/23
|
29/01/24
|
-
|
-
|
-
|
Fiscal Period: October |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-2.373
|
-5.363
|
-4.822
|
-5.794
|
-8.334
|
-8.501
|
-9.699
|
-10.16
|
-
|
-9.923
|
-7.7
|
-7.1
|
-5.8
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-8.452
|
-8.608
|
-9.808
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-5.831
|
-8.21
|
-8.015
|
-9.347
|
-9.932
|
-11.7
|
-
|
-
|
-9.336
|
-9.988
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-5.831
|
-8.21
|
-8.015
|
-9.347
|
-9.932
|
-11.7
|
-
|
-
|
-9.336
|
-9.988
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
-0.0200
|
-0.0200
|
-0.0200
|
-0.0300
|
-0.0300
|
-0.0300
|
-0.0300
|
-0.0400
|
-0.0300
|
-0.0267
|
-0.0300
|
-0.0267
|
-0.0300
|
-0.0300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/02/22
|
29/03/22
|
27/06/22
|
14/09/22
|
26/01/23
|
16/03/23
|
13/06/23
|
13/09/23
|
29/01/24
|
18/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
8.72
|
23.6
|
17.7
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-7.07
|
-60.8
|
-30.4
|
3.86
|
-30.8
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-130%
|
-
|
-3,513%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
-
|
0.0400
|
0.0600
|
0.0400
|
-
|
Cash Flow per Share
2 |
-
|
-
|
-
|
-
|
-0.1000
|
-0.0700
|
-0.0800
|
-0.0900
|
Capex
1 |
-
|
-
|
0.23
|
46.3
|
0.1
|
0.03
|
0.1
|
0.04
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
19.97%
|
Announcement Date
|
14/02/20
|
01/02/21
|
14/02/22
|
26/01/23
|
29/01/24
|
-
|
-
|
-
|
Last Close Price
0.37
CAD Average target price
3.02
CAD Spread / Average Target +716.22% Consensus |
1st Jan change
|
Capi.
|
---|
| +10.39% | 126B | | -6.86% | 10.96B | | +2.52% | 8.97B | | +38.96% | 5.56B | | -17.50% | 4.99B | | +8.36% | 3.44B | | -8.84% | 2.8B | | -7.52% | 2.18B | | -3.00% | 2.16B |
Medical Devices & Implants
|